Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Change in Cash (2018 - 2025)

Historic Change in Cash for Neurogene (NGNE) over the last 6 years, with Q3 2025 value amounting to $12.2 million.

  • Neurogene's Change in Cash rose 12746.01% to $12.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year decrease of 7957.87%. This contributed to the annual value of -$11.8 million for FY2024, which is 11768.15% down from last year.
  • According to the latest figures from Q3 2025, Neurogene's Change in Cash is $12.2 million, which was up 12746.01% from -$12.0 million recorded in Q2 2025.
  • In the past 5 years, Neurogene's Change in Cash registered a high of $103.2 million during Q4 2023, and its lowest value of -$65.8 million during Q1 2025.
  • In the last 3 years, Neurogene's Change in Cash had a median value of -$12.0 million in 2025 and averaged -$970636.4.
  • Data for Neurogene's Change in Cash shows a peak YoY increase of 12746.01% (in 2025) and a maximum YoY decrease of 383736.51% (in 2025) over the last 5 years.
  • Neurogene's Change in Cash (Quarter) stood at $103.2 million in 2023, then tumbled by 32.19% to $70.0 million in 2024, then plummeted by 82.57% to $12.2 million in 2025.
  • Its Change in Cash stands at $12.2 million for Q3 2025, versus -$12.0 million for Q2 2025 and -$65.8 million for Q1 2025.